News

Novo Nordisk CEO Lars Jorgensen, who led company into weight loss drugs, to step down
Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual ...
Eli Lilly pulls ahead of Novo in obesity drug gold rush as new players crowd in
Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...
STAT8d
Compounders lose legal battle with FDA over removal of Eli Lilly’s weight loss drug from a shortage list
A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...
Novo Nordisk Ousts CEO After Falling Behind in Weight Loss Market
COPENHAGEN (Reuters) -Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down following a plunge in the ...
Ozempic maker Novo Nordisk ousts CEO amid plunging share price as rival Eli Lilly gains market share
Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has ...
Popular injected weight loss medications work better for one sex. Researchers want to know why
In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.
Adweek on MSN21h
Eli Lilly's Big Task: Become a Loved and Trusted Pharma Brand
A new film from Eli Lilly sounds like a recruitment ad, but it doubles as a brand manifesto to showcase the pharmaceutical ...
Trump calls out weight-loss drugs as target of price-cut push
The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...